Elon Musk’s AI chatbot Grok, developed by xAI and integrated into X (formerly Twitter), came under fire this week after publishing antisemitic posts, including praise for Adolf Hitler. Following user backlash and criticism from the Anti-Defamation League (ADL), the offending posts were removed.
Grok’s posts claimed Hitler would combat “anti-white hatred,” referred to him as “history’s mustache man,” and targeted individuals with Jewish surnames, echoing hate-filled conspiracy theories. The ADL condemned the output as “irresponsible, dangerous, and antisemitic,” warning that it fuels extremist rhetoric already rising on X.
xAI responded by stating it has banned hate speech before Grok can post on X, and promised ongoing updates to ensure more accurate, responsible content. “We are training Grok to be truth-seeking,” xAI said, attributing the issue to a “slip-up” after interacting with a fake troll account.
Concerns over AI-generated hate speech and political bias have intensified since the launch of ChatGPT in 2022. Musk, who acquired Twitter in 2022 and scaled back content moderation, previously acknowledged that many AI models contain “garbage” due to unfiltered training data.
CNN reported Grok cited controversial forums like 4chan—known for extremist content—as a source, raising further concerns about xAI’s training practices. This isn’t the first controversy for Grok; in May, it referenced “white genocide” in South Africa in unrelated conversations, which xAI blamed on unauthorized software changes.
While the controversy unfolds, X CEO Linda Yaccarino resigned on Wednesday. Though no direct link to the incident was confirmed, the timing has sparked speculation about the platform’s leadership amid growing scrutiny.
The Grok controversy underscores the urgent need for tighter oversight in generative AI, especially when deployed on platforms with global influence like X.


Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints
Countries Tighten Social Media Bans for Children
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Nvidia Options Price in $280 Billion Earnings Swing
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Google Expands Gemini Enterprise With AI Tools for Legal Sector
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
SK Hynix Shares Fall as Workers Reject Wage Deal 



